Sangamo Therapeutics (SGMO) Earnings Date & Reports

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SGMO is expected to report earnings to fall 337.50% to -9 cents per share on March 17

Sangamo Therapeutics SGMO Stock Earnings Reports

Q4'24

Est.

$-0.09

Q3'24

Beat

by $0.06

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.08

Q4'23

Missed

by $0.08

The last earnings report on November 12 showed earnings per share of 3 cents, beating the estimate of -1 cents. With 780.47K shares outstanding, the current market capitalization sits at 206.29M.

View a ticker or compare two or three

Compare

SGMO